KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $3.2 billion.

  • Thermo Fisher Scientific's Other Accumulated Expenses fell 542.29% to $3.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 billion, marking a year-over-year decrease of 542.29%. This contributed to the annual value of $3.2 billion for FY2024, which is 144.79% down from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Other Accumulated Expenses of $3.2 billion as of Q3 2025, which was down 542.29% from $3.2 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Other Accumulated Expenses ranged from a high of $3.4 billion in Q3 2024 and a low of $1.9 billion during Q3 2021
  • For the 5-year period, Thermo Fisher Scientific's Other Accumulated Expenses averaged around $2.9 billion, with its median value being $3.0 billion (2024).
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first surged by 5889.31% in 2022, then plummeted by 1116.66% in 2023.
  • Thermo Fisher Scientific's Other Accumulated Expenses (Quarter) stood at $3.0 billion in 2021, then rose by 13.69% to $3.4 billion in 2022, then decreased by 3.22% to $3.2 billion in 2023, then dropped by 1.45% to $3.2 billion in 2024, then grew by 0.31% to $3.2 billion in 2025.
  • Its Other Accumulated Expenses was $3.2 billion in Q3 2025, compared to $3.2 billion in Q2 2025 and $3.0 billion in Q1 2025.